Jérémie Mortier
Title
Cited by
Cited by
Year
The impact of molecular dynamics on drug design: applications for the characterization of ligand–macromolecule complexes
J Mortier, C Rakers, M Bermudez, MS Murgueitio, S Riniker, G Wolber
Drug Discovery Today 20 (6), 686-702, 2015
1182015
NF-κB inducing kinase (NIK) inhibitors: Identification of new scaffolds using virtual screening
J Mortier, B Masereel, C Remouchamps, C Ganeff, J Piette
Bioorganic & medicinal chemistry letters 20 (15), 4515-4520, 2010
512010
Anthocyanin composition, antioxidant efficiency, and α-amylase inhibitor activity of different Hungarian sour cherry varieties (Prunus cerasus L.)
JR Homoki, A Nemes, E Fazekas, G Gyémánt, P Balogh, F Gál, J Al-Asri, ...
Food chemistry 194, 222-229, 2016
472016
Design, synthesis and molecular docking study of novel quinoxalin-2 (1H)-ones as anti-tumor active agents with inhibition of tyrosine kinase receptor and studying their …
SA Galal, SHM Khairat, FAF Ragab, AS Abdelsamie, MM Ali, SM Soliman, ...
European journal of medicinal chemistry 86, 122-132, 2014
422014
Synthesis, biological activity and structure–activity relationships of new benzoic acid-based protein tyrosine phosphatase inhibitors endowed with insulinomimetic effects in …
R Ottanŕ, R Maccari, J Mortier, A Caselli, S Amuso, G Camici, A Rotondo, ...
European journal of medicinal chemistry 71, 112-127, 2014
362014
More than a look into a crystal ball: protein structure elucidation guided by molecular dynamics simulations
M Bermudez, J Mortier, C Rakers, D Sydow, G Wolber
Drug Discovery Today 21 (11), 1799-1805, 2016
342016
Computational tools for in silico fragment-based drug design
J Mortier, C Rakers, R Frederick, G Wolber
Current topics in medicinal chemistry 12 (17), 1935-1943, 2012
342012
Impact of fluorination on proteolytic stability of peptides: a case study with α-chymotrypsin and pepsin
V Asante, J Mortier, G Wolber, B Koksch
Amino acids 46 (12), 2733-2744, 2014
302014
Inhibitory potency of flavonoid derivatives on influenza virus neuraminidase
C Rakers, SM Schwerdtfeger, J Mortier, S Duwe, T Wolff, G Wolber, ...
Bioorganic & medicinal chemistry letters 24 (17), 4312-4317, 2014
302014
Computational close up on protein–protein interactions: how to unravel the invisible using molecular dynamics simulations?
C Rakers, M Bermudez, BG Keller, J Mortier, G Wolber
Wiley Interdisciplinary Reviews: Computational Molecular Science 5 (5), 345-359, 2015
282015
Design, synthesis and structure–activity relationship of novel quinoxaline derivatives as cancer chemopreventive agent by inhibition of tyrosine kinase receptor
SA Galal, AS Abdelsamie, SM Soliman, J Mortier, G Wolber, MM Ali, ...
European journal of medicinal chemistry 69, 115-124, 2013
282013
In silico virtual screening approaches for anti-viral drug discovery
MS Murgueitio, M Bermudez, J Mortier, G Wolber
Drug Discovery Today: Technologies 9 (3), e219-e225, 2012
262012
Design, synthesis, inhibition studies, and molecular modeling of pepstatin analogues addressing different secreted aspartic proteinases of Candida albicans
CD Cadicamo, J Mortier, G Wolber, M Hell, IE Heinrich, D Michel, ...
Biochemical pharmacology 85 (7), 881-887, 2013
222013
3D-QSAR, design, synthesis and characterization of trisubstituted harmine derivatives with in vitro antiproliferative properties
C Meinguet, C Bruyčre, R Frédérick, V Mathieu, C Vancraeynest, ...
European journal of medicinal chemistry 94, 45-55, 2015
212015
Pyrazolo [4, 3-c] isoquinolines as potential inhibitors of NF-κB activation
J Mortier, R Frederick, C Ganeff, C Remouchamps, P Talaga, L Pochet, ...
Biochemical pharmacology 79 (10), 1462-1472, 2010
202010
Tailored presentation of carbohydrates on a coiled coil-based scaffold for asialoglycoprotein receptor targeting
E Zacco, J Hütter, JL Heier, J Mortier, PH Seeberger, B Lepenies, ...
ACS chemical biology 10 (9), 2065-2072, 2015
182015
Identification of PPARγ agonists from natural sources using different in silico approaches
RB El-Houri, J Mortier, MS Murgueitio, G Wolber, LP Christensen
Planta medica 81 (06), 488-494, 2015
172015
Impact of fluorination on proteolytic stability of peptides in human blood plasma
V Asante, J Mortier, H Schlüter, B Koksch
Bioorganic & medicinal chemistry 21 (12), 3542-3546, 2013
172013
Anti-virulence strategy against Brucella suis: synthesis, biological evaluation and molecular modeling of selective histidinol dehydrogenase inhibitors
MR Abdo, P Joseph, J Mortier, F Turtaut, JL Montero, B Masereel, ...
Organic & biomolecular chemistry 9 (10), 3681-3690, 2011
162011
Arginase structure and inhibition: catalytic site plasticity reveals new modulation possibilities
J Mortier, JRC Prévost, D Sydow, S Teuchert, C Omieczynski, ...
Scientific reports 7 (1), 1-9, 2017
142017
The system can't perform the operation now. Try again later.
Articles 1–20